Teachers Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
$11.9M Buy
127,013
+8,967
+8% +$838K 0.01% 907
2018
Q4
$8.61M Buy
118,046
+6,593
+6% +$481K 0.01% 1005
2018
Q3
$9.75M Buy
111,453
+151
+0.1% +$13.2K 0.01% 1086
2018
Q2
$11M Buy
111,302
+3,812
+4% +$375K 0.01% 1041
2018
Q1
$12.8M Buy
107,490
+4,709
+5% +$561K 0.02% 927
2017
Q4
$13.1M Buy
102,781
+7,911
+8% +$1.01M 0.02% 935
2017
Q3
$11.1M Buy
94,870
+10,191
+12% +$1.2M 0.02% 982
2017
Q2
$6.75M Buy
84,679
+4,441
+6% +$354K 0.01% 1181
2017
Q1
$4.11M Buy
80,238
+6,662
+9% +$341K 0.01% 1397
2016
Q4
$2.76M Buy
73,576
+7,048
+11% +$264K ﹤0.01% 1600
2016
Q3
$4.51M Buy
66,528
+3,114
+5% +$211K 0.01% 1258
2016
Q2
$3.52M Buy
63,414
+3,897
+7% +$216K 0.01% 1340
2016
Q1
$3.74M Sell
59,517
-52,120
-47% -$3.27M 0.01% 1256
2015
Q4
$10.5M Sell
111,637
-52,991
-32% -$4.99M 0.02% 852
2015
Q3
$13.2M Buy
164,628
+4,487
+3% +$361K 0.03% 717
2015
Q2
$19.2M Buy
160,141
+62,948
+65% +$7.55M 0.04% 574
2015
Q1
$10.1M Buy
97,193
+50,490
+108% +$5.27M 0.02% 884
2014
Q4
$4.53M Sell
46,703
-50,612
-52% -$4.91M 0.01% 1180
2014
Q3
$7.6M Sell
97,315
-676
-0.7% -$52.8K 0.02% 990
2014
Q2
$6.19M Sell
97,991
-41,114
-30% -$2.6M 0.01% 1059
2014
Q1
$9.34M Buy
139,105
+55,870
+67% +$3.75M 0.02% 839
2013
Q4
$5.36M Buy
83,235
+2,671
+3% +$172K 0.01% 1061
2013
Q3
$5.16M Buy
80,564
+3,732
+5% +$239K 0.01% 1020
2013
Q2
$2.38M Buy
+76,832
New +$2.38M 0.01% 1325